Skip to Main Content

Paper Details

One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis.
Amyloid
24
2019
Author NameAffiliation
Andrew EisenbergerColumbia University Medical Center
  • 1 - 1

Datasets

Release 1.2